99 related articles for article (PubMed ID: 14142213)
1. [THE USE OF CHYMORAL IN BURNED PATIENTS].
PESSEREAU G; MONTEIL R
Rev Int Serv Sante Armees; 1964 Mar; 37():193-7. PubMed ID: 14142213
[No Abstract] [Full Text] [Related]
2. THE USE OF CHYMORAL IN BURNS.
PESSEREAU G; MONTEIL R
Rev Int Serv Sante Armees; 1964 May; 37():355-9. PubMed ID: 14197534
[No Abstract] [Full Text] [Related]
3. Use of "chymoral" in mucoviscidosis.
STANFIELD JP
Br Med J; 1963 Mar; 1(5332):727-8. PubMed ID: 13983368
[No Abstract] [Full Text] [Related]
4. [CHYMORAL. CLINICAL ANALYSIS OF ITS THERAPEUTIC POSSIBILITIES].
HAAG R; NICOLAS P; LANGER MC
Strasb Med; 1963 Sep; 14():695-701. PubMed ID: 14092048
[No Abstract] [Full Text] [Related]
5. [CHYMORAL AND COAGULATION].
PESSEREAU G; MONTEIL R
Rev Int Serv Sante Armees; 1963 Nov; 36():647-59. PubMed ID: 14094765
[No Abstract] [Full Text] [Related]
6. CHYMORAL AND COAGULATION.
PESSEREAU G; MONTEIL R
Rev Int Serv Sante Armees; 1963 Dec; 36():745-57. PubMed ID: 14102522
[No Abstract] [Full Text] [Related]
7. Effect of trypsin-chymotrypsin (Chymoral Forte D.S.) preparation on the modulation of cytokine levels in burn patients.
RaviKumar T; Ramakrishnan M; Jayaraman V; Babu M
Burns; 2001 Nov; 27(7):709-16. PubMed ID: 11600250
[TBL] [Abstract][Full Text] [Related]
8. Action of trypsin:chymotrypsin (Chymoral forte DS) preparation on acute-phase proteins following burn injury in humans.
Latha B; Ramakrishnan KM; Jayaraman V; Babu M
Burns; 1997 Mar; 23 Suppl 1():S3-7. PubMed ID: 9177894
[TBL] [Abstract][Full Text] [Related]
9. Effect of chymoral on epididymitis.
WOGALTER H
J Urol; 1962 Mar; 87():444-6. PubMed ID: 14007840
[No Abstract] [Full Text] [Related]
10. [Reevaluation of oral chymotrypsin preparation (Chymoral) in orodental surgical field].
Takematsu K; Izumi S; Komatani K; Kojima N; Miyamoto H
Shikai Tenbo; 1978; 52(2):359-64. PubMed ID: 295905
[No Abstract] [Full Text] [Related]
11. [Alpha-chymotrypsin in the sequelae of burns].
PESSEREAU G; GELY
Rev Int Serv Sante Armees; 1963 May; 36():329-31. PubMed ID: 13942671
[No Abstract] [Full Text] [Related]
12. [Chymoral for inflammatory diseases in the orodental area].
Kobayashi T; Ozone H; Kamei H; Ishimaru K
Shikai Tenbo; 1984 Oct; 64(4):813-8. PubMed ID: 6597599
[No Abstract] [Full Text] [Related]
13. [Trypsin, chymotrypsin, kallidin and bradykinin].
WERLE E; KEHL R; KOEBKE K
Biochem Z; 1950; 321(3):213-20. PubMed ID: 14800984
[No Abstract] [Full Text] [Related]
14. [USE OF A COMBINATION OF ORAL ALPHA-CHYMOTRYPSIN AND TRYPSIN IN GENERAL SURGERY].
GALAVERNA J; MONSAINGEON A
Rev Int Serv Sante Armees; 1964; 37():603-8. PubMed ID: 14212635
[No Abstract] [Full Text] [Related]
15. [THE TETRACYCLINE HC1, TRYPSIN AND CHYMOTRYPSIN COMBINATION: CHYMOCYCLINE].
HAAG R; NICOLAS P
Strasb Med; 1964 May; 15():390-5. PubMed ID: 14178556
[No Abstract] [Full Text] [Related]
16. The effects of trypsin and chymotrypsin on the acetylcholinesterase content of human erythrocytes.
FIRKIN BG; BEAL RW; MITCHELL G
Australas Ann Med; 1963 Feb; 12():26-9. PubMed ID: 13945235
[No Abstract] [Full Text] [Related]
17. [Effect of trypsin and of chymotrypsin on sturine].
LOKSHINA LA
Biokhimiia; 1955; 20(3):339-45. PubMed ID: 13260286
[No Abstract] [Full Text] [Related]
18. The digestion of casein by crystalline trypsin and chymotrypsin.
EVERITT EL; HESS WC
Bull Georgetown Univ Med Cent; 1952; 5(6):175-8. PubMed ID: 14935440
[No Abstract] [Full Text] [Related]
19. [ON THE SANARELLI-SHWARTZMAN LOCAL PHENOMENON. I. INFLUENCE OF AN ASSOCIATION OF TRYPSIN, CHYMOTRYPSIN AND "TRIPSEPAR"].
D AMICO G
G Ital Chir; 1964 Mar; 20():191-217. PubMed ID: 14203868
[No Abstract] [Full Text] [Related]
20. [ON THE UTILIZATION OF ORAL TRYPSIN AND CHYMOTRYPSIN. CLINICAL EVALUATION].
LODI R; ZAMBARDA E
Minerva Med; 1964 Dec; 55():4123-8. PubMed ID: 14258594
[No Abstract] [Full Text] [Related]
[Next] [New Search]